Tickerplace logo

Tickerplace

Invex Therapeutics Ltd logo

IXCInvex Therapeutics Ltd

IXC Stock Price, Valuation & Chart | Invex Therapeutics Ltd

Compare
$0.110+0.00 (+0.00%)

At close · 31 Aug 2026, 12:16 am

Sector: HealthcareIXC intrinsic valueIXC calculated fair value vs priceWebsite
OverviewFinancialsDividendsRatios

IXC Historical price chart

IXC Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization8.27M
PE Ratio-9.92
EPS-0.01
Trading Volume3.00K
Today's High/Low0.11/0.11
Dividend Yield0.00
52 Week High/Low0.18/0.09
Shares Outstanding75.15M
IXC Financial Statement
IXC Analyst ratings
IXC Analysis & performance metrics

IXC Company profile

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in…

IXC Management team

Management
Narelle Warren B.Com, B.Com., L.L.B., LLBCFO
Chief Financial Officer & Company Secretary
Thomas Duthy M.B.A., Ph.D.CTO
Executive Director
Total 2 executives

IXC Frequently asked questions

What is Invex Therapeutics Ltd (IXC) Stock Price?

Current stock price of Invex Therapeutics Ltd (IXC) stock is $0.110. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Invex Therapeutics Ltd (IXC) stock is 3.00K.

Last updated at 31 Aug 2026, 12:16 am.

Why is the Invex Therapeutics Ltd (IXC) stock price going up or down today?

The stock price of Invex Therapeutics Ltd (IXC) can change with earnings, company news, and overall market sentiment. Invex Therapeutics Ltd operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Invex Therapeutics Ltd stock expensive at its current price?

Whether Invex Therapeutics Ltd looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IXC on this page is -9.92. EPS on this page is -0.01. Compare those figures with peers and growth expectations before deciding if the current Invex Therapeutics Ltd price is justified.

How has the stock price of Invex Therapeutics Ltd (IXC) performed historically?

Historical performance for Invex Therapeutics Ltd (IXC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IXC reacted to past earnings and market events.

Should I buy Invex Therapeutics Ltd (IXC) stock, at this price?

Buying Invex Therapeutics Ltd (IXC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.